Related Experiment Video
Updated: Jun 3, 2026
Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
Published on: February 23, 2024
Spinal cord histopathology of MOG peptide 35-55-induced experimental autoimmune encephalomyelitis is time- and
Mascha S Recks1, Klaus Addicks, Stefanie Kuerten
1Department of Anatomy I, University of Cologne, Joseph-Stelzmann-Str. 9, 50931 Cologne, Germany.
Abstract:
In the present study, we demonstrate that the histopathologic features of myelin oligodendrocyte glycoprotein (MOG) peptide 35-55-induced experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice closely mirror the hallmarks of MS pathology. On the one hand, we depict a time-dependent transition from acute inflammation to chronic neurodegeneration in spinal cord histopathology and provide distinct criteria (i.e. parenchymal edema, cellular infiltration and perivascular inflammatory infiltrates) by which acute and chronic stages of the disease can be distinguished. On the other hand, we assessed the extent of spinal cord plaque formation in relation to the total white matter area and we demonstrate a strong correlation with the clinical disease severity. Additionally, we report on the involvement of different spinal cord regions, focusing on the anterolateral, posterior and pyramidal tract. Our results help to further characterize histopathology of MOG peptide 35-55-induced EAE and reinforce the importance of this model for structural and functional studies of MS features.
Insights
Myelin oligodendrocyte glycoprotein (MOG) peptide 35-55-induced experimental autoimmune encephalomyelitis (EAE) in mice closely mimics multiple sclerosis (MS) pathology. This study details disease progression and spinal cord involvement, validating EAE as an MS model.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Multiple Sclerosis (MS) is a chronic neuroinflammatory disease characterized by demyelination and neurodegeneration.
- Animal models are crucial for understanding MS pathogenesis and testing therapeutic strategies.
Purpose of the Study:
- To characterize the histopathological features of MOG peptide 35-55-induced experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice.
- To establish criteria for distinguishing acute and chronic EAE stages.
- To correlate spinal cord pathology with clinical disease severity in an MS model.
Main Methods:
- Induction of EAE in C57BL/6 mice using MOG peptide 35-55.
- Histopathological analysis of spinal cord tissue at various time points.
- Assessment of parenchymal edema, cellular infiltration, perivascular infiltrates, and plaque formation.
- Correlation analysis between histopathology and clinical scores.
Main Results:
- EAE histopathology closely resembles MS hallmarks, including acute inflammation transitioning to chronic neurodegeneration.
- Distinct criteria for acute (edema, infiltration) and chronic (plaque formation) EAE stages were identified.
- Spinal cord plaque formation strongly correlated with clinical disease severity.
- Specific spinal cord regions, including anterolateral, posterior, and pyramidal tracts, showed differential involvement.
Conclusions:
- MOG peptide 35-55-induced EAE is a valuable preclinical model for studying MS.
- The characterized histopathological features provide a framework for evaluating disease progression and therapeutic interventions in MS research.
More Related Videos
08:03Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
Published on: April 15, 2014
13:02Sagittal Plane Kinematic Gait Analysis in C57BL/6 Mice Subjected to MOG35-55 Induced Experimental Autoimmune Encephalomyelitis
Published on: November 4, 2017